These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 25373117

  • 1. Impact of prenatal exposure to serotonin reuptake inhibitors or maternal major depressive disorder on infant developmental outcomes.
    Santucci AK, Singer LT, Wisniewski SR, Luther JF, Eng HF, Dills JL, Sit DK, Hanusa BH, Wisner KL.
    J Clin Psychiatry; 2014 Oct; 75(10):1088-95. PubMed ID: 25373117
    [Abstract] [Full Text] [Related]

  • 2. One-Year Developmental Outcomes for Infants of Mothers With Bipolar Disorder.
    Santucci AK, Singer LT, Wisniewski SR, Luther JF, Eng HF, Sit DK, Wisner KL.
    J Clin Psychiatry; 2017 Oct; 78(8):1083-1090. PubMed ID: 28068465
    [Abstract] [Full Text] [Related]

  • 3. Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatment.
    Salisbury AL, Wisner KL, Pearlstein T, Battle CL, Stroud L, Lester BM.
    Depress Anxiety; 2011 Nov; 28(11):1008-19. PubMed ID: 21898709
    [Abstract] [Full Text] [Related]

  • 4. Infant developmental outcomes following prenatal exposure to antidepressants, and maternal depressed mood and positive affect.
    Hanley GE, Brain U, Oberlander TF.
    Early Hum Dev; 2013 Aug; 89(8):519-24. PubMed ID: 23384962
    [Abstract] [Full Text] [Related]

  • 5. Fine Motor Differences and Prenatal Serotonin Reuptake Inhibitors Exposure.
    Partridge MC, Salisbury AL, LaGasse LL.
    J Pediatr; 2016 Aug; 175():144-149.e1. PubMed ID: 27215778
    [Abstract] [Full Text] [Related]

  • 6. Major depressive disorder during pregnancy: Psychiatric medications have minimal effects on the fetus and infant yet development is compromised.
    Gustafsson HC, Goodman SH, Feng T, Choi J, Lee S, Newport DJ, Knight B, Pingeton B, Stowe ZN, Monk C.
    Dev Psychopathol; 2018 Aug; 30(3):773-785. PubMed ID: 30068426
    [Abstract] [Full Text] [Related]

  • 7. Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development.
    Casper RC, Gilles AA, Fleisher BE, Baran J, Enns G, Lazzeroni LC.
    Psychopharmacology (Berl); 2011 Sep; 217(2):211-9. PubMed ID: 21499702
    [Abstract] [Full Text] [Related]

  • 8. Are maternal depression or symptom severity associated with breastfeeding intention or outcomes?
    Bogen DL, Hanusa BH, Moses-Kolko E, Wisner KL.
    J Clin Psychiatry; 2010 Aug; 71(8):1069-78. PubMed ID: 20584521
    [Abstract] [Full Text] [Related]

  • 9. Mother-infant antidepressant concentrations, maternal depression, and perinatal events.
    Sit D, Perel JM, Wisniewski SR, Helsel JC, Luther JF, Wisner KL.
    J Clin Psychiatry; 2011 Jul; 72(7):994-1001. PubMed ID: 21824458
    [Abstract] [Full Text] [Related]

  • 10. Prenatal exposure to antidepressants and depressed maternal mood alter trajectory of infant speech perception.
    Weikum WM, Oberlander TF, Hensch TK, Werker JF.
    Proc Natl Acad Sci U S A; 2012 Oct 16; 109 Suppl 2(Suppl 2):17221-7. PubMed ID: 23045665
    [Abstract] [Full Text] [Related]

  • 11. Neonatal Discontinuation Syndrome in Serotonergic Antidepressant-Exposed Neonates.
    Yang A, Ciolino JD, Pinheiro E, Rasmussen-Torvik LJ, Sit DKY, Wisner KL.
    J Clin Psychiatry; 2017 May 16; 78(5):605-611. PubMed ID: 28570796
    [Abstract] [Full Text] [Related]

  • 12. Level of prenatal cocaine exposure and scores on the Bayley Scales of Infant Development: modifying effects of caregiver, early intervention, and birth weight.
    Frank DA, Jacobs RR, Beeghly M, Augustyn M, Bellinger D, Cabral H, Heeren T.
    Pediatrics; 2002 Dec 16; 110(6):1143-52. PubMed ID: 12456912
    [Abstract] [Full Text] [Related]

  • 13. The impact of prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure and maternal mood on mother-infant interactions at 3 months of age.
    Weikum WM, Mayes LC, Grunau RE, Brain U, Oberlander TF.
    Infant Behav Dev; 2013 Dec 16; 36(4):485-93. PubMed ID: 23728194
    [Abstract] [Full Text] [Related]

  • 14. The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month.
    Salisbury AL, O'Grady KE, Battle CL, Wisner KL, Anderson GM, Stroud LR, Miller-Loncar CL, Young ME, Lester BM.
    Am J Psychiatry; 2016 Feb 01; 173(2):147-57. PubMed ID: 26514656
    [Abstract] [Full Text] [Related]

  • 15. Neurodevelopmental outcomes following prenatal exposure to serotonin reuptake inhibitor antidepressants: a "social teratogen" or moderator of developmental risk?
    Hanley GE, Oberlander TF.
    Birth Defects Res A Clin Mol Teratol; 2012 Aug 01; 94(8):651-9. PubMed ID: 22733632
    [Abstract] [Full Text] [Related]

  • 16. Preschool outcomes following prenatal serotonin reuptake inhibitor exposure: differences in language and behavior, but not cognitive function.
    Johnson KC, Smith AK, Stowe ZN, Newport DJ, Brennan PA.
    J Clin Psychiatry; 2016 Feb 01; 77(2):e176-82. PubMed ID: 26930533
    [Abstract] [Full Text] [Related]

  • 17. Associations Between Brain Structure and Connectivity in Infants and Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy.
    Lugo-Candelas C, Cha J, Hong S, Bastidas V, Weissman M, Fifer WP, Myers M, Talati A, Bansal R, Peterson BS, Monk C, Gingrich JA, Posner J.
    JAMA Pediatr; 2018 Jun 01; 172(6):525-533. PubMed ID: 29630692
    [Abstract] [Full Text] [Related]

  • 18. Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors.
    Pawluski JL, Galea LA, Brain U, Papsdorf M, Oberlander TF.
    Pediatrics; 2009 Oct 01; 124(4):e662-70. PubMed ID: 19786426
    [Abstract] [Full Text] [Related]

  • 19. SSRIs and SNRIs (SRI) in Pregnancy: Effects on the Course of Pregnancy and the Offspring: How Far Are We from Having All the Answers?
    Ornoy A, Koren G.
    Int J Mol Sci; 2019 May 14; 20(10):. PubMed ID: 31091646
    [Abstract] [Full Text] [Related]

  • 20. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications.
    Moses-Kolko EL, Bogen D, Perel J, Bregar A, Uhl K, Levin B, Wisner KL.
    JAMA; 2005 May 18; 293(19):2372-83. PubMed ID: 15900008
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.